Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs Kaltura Inc (KLTR) Price & Performance

Gilead Sciences, Inc.Trade
Kaltura IncTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs Kaltura Inc — how do they compare? Gilead Sciences, Inc. trades at $135.28 (market cap $168.35B), while Kaltura Inc trades at $1.63 (market cap $249.42M). The key difference: Gilead Sciences, Inc. is far larger — about 675× Kaltura Inc's market cap, and Gilead Sciences, Inc. pays a 2.42% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.

GILDKLTR
Market Cap
$168.35B$249.42M
Sector
HealthTechnology
52-Week High
$155.80$1.89
52-Week Low
$110.56$1.08
Enterprise Value
$191.42B$261.64M
Dividend Yield
2.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About Kaltura Inc

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)

Read more on KLTR